13. Stock-Based Compensation

 

Equity Incentive Plans – The Company’s 2013 Equity Compensation Plan (the “2013 Plan”) was adopted for the purpose of providing equity incentives to employees, officers, directors and consultants including options, restricted stock, restricted stock units, stock appreciation rights, other equity awards, annual incentive awards and dividend equivalents. Through a series of amendments to the 2013 Plan, the total number of authorized shares available for issuance of common stock under the Plan was 75,000 shares.

 

On April 11, 2023, the Board of Directors adopted a new equity incentive plan, the Professional Diversity Network, Inc. 2023 Equity Compensation Plan (the “2023 Equity Compensation Plan”). The 2023 Equity Compensation Plan was approved by the Company’s stockholders on June 15, 2023. The 2023 Equity Compensation Plan supersedes and replaces the 2013 Plan, and no new awards will be granted under the 2013 Plan. Any awards outstanding under the 2013 Plan remain subject to and will be paid under the 2013 Plan. The 2023 Equity Compensation Plan reserves 75,000 shares of common stock for issuance of awards to directors, officers, employees and qualifying consultants of the Company and its affiliates.

 

Stock Options

 

The fair value of options is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes pricing model is affected by the Company’s stock price, as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The risk-free rate is based on the U.S. Treasury rate for the expected life at the time of grant, volatility is based on the average long-term implied volatilities of peer companies, the expected life is based on the estimated average of the life of options using the simplified method, and forfeitures are estimated on the date of grant based on certain historical data. The Company utilizes the simplified method to determine the expected life of its options due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

 

Forfeitures are required to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

 

The following table summarizes the Company’s stock option activity for the years ended December 31, 2024, and 2023:

 

          

Weighted

     
          

Average

     
      

Weighted

  

Remaining

  

Aggregate

 
      

Average

  

Contractual

  

Intrinsic

 
  

Number of

  

Exercise

  

Life

  

Value

 
  

Options

  

Price

  

(in Years)

  

(in thousands)

 

Outstanding - January 1, 2024

  3,306  $90.04   5.7  $- 

Granted

  -   -         

Exercised

  -   -         

Forfeited

  (1,806)  -         

Outstanding - December 31, 2024

  1,500  $44.60   4.2  $- 
                 

Exercisable at December 31, 2024

  1,500  $44.60   4.2  $- 

 

          

Weighted

     
          

Average

     
      

Weighted

  

Remaining

  

Aggregate

 
      

Average

  

Contractual

  

Intrinsic

 
  

Number of

  

Exercise

  

Life

  

Value

 
  

Options

  

Price

  

(in Years)

  

(in thousands)

 

Outstanding - January 1, 2023

  3,306  $90.40   6.8  $- 

Granted

  -   -         

Exercised

  -   -         

Forfeited

  -   -         

Outstanding - December 31, 2023

  3,306  $90.04   5.7  $- 
                 

Exercisable at December 31, 2023

  2,806  $99.10   5.5  $- 

 

There were no stock options granted in fiscal 2024 or 2023.

 

The Company recorded non-cash stock-based compensation expense of approximately $0 and $10,850 as a component of general and administrative expenses in the accompanying consolidated statements of operations for the years ended December 31, 2024, and 2023, pertaining to stock options awards.

 

Warrants

 

As of December 31, 2024, and 2023, there were no warrants outstanding and exercisable.

 

Restricted Stock

 

A summary of restricted stock activity for the years ended December 31, 2024, and 2023 is as follows:

 

  

Number of

 
  

Shares

 

Outstanding - January 1, 2023

  6,911 

Granted

  11,733 

Forfeited

  (1,382)

Vested

  (5,529)

Outstanding - December 31, 2023

  11,733 

Granted

  28,890 

Forfeited

  (4,847)

Vested

  (11,123)

Outstanding - December 31, 2024

  24,653 

 

During the year ended December 31, 2024 the Company granted 20,653 restricted stock units (“RSUs”) to non-employee directors as partial compensation for their service as a director. The aggregate grant date fair value of the combined awards amounted to approximately $121,849. The RSU award to the Board member fully vests on the one-year anniversary after the date of grant. The Company also granted 40,000 RSUs to certain officers and managers with immediate vesting. The aggregate grant date fair value of the combined awards amounted to approximately $23,600.

 

During the year ended December 31, 2023 the Company granted 3,049 restricted stock units (“RSUs”) to non-employee directors as partial compensation for their service as a director. The aggregate grant date fair value of the combined awards amounted to approximately $125,000. The RSU award to the Board member fully vests on the one-year anniversary after the date of grant. The Company also granted 8,618 RSUs to certain officers and managers with immediate vesting. The aggregate grant date fair value of the combined awards amounted to approximately $193,000.

 

The Company recorded non-cash stock-based compensation expense of approximately $175,000 and $300,000 as a component of general and administrative expenses in the accompanying consolidated statements of operations for the years ended December 31, 2024, and 2023, respectively, pertaining to restricted stock awards.

 

Total unrecognized stock-based compensation expense related to unvested restricted stock at December 31, 2024 was approximately $20,000 and is expected to be recognized through the third quarter of 2025.

 

Historical Timeline

Fiscal YearFiled
2024Mar 31, 2025Showing above
2017Mar 30, 2018

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.